Literature DB >> 12738236

Na+ channel mutation leading to loss of function and non-progressive cardiac conduction defects.

Lucas J Herfst1, Franck Potet, Connie R Bezzina, W Antoinette Groenewegen, Hervé Le Marec, Theo M Hoorntje, Sophie Demolombe, Isabelle Baró, Denis Escande, Habo J Jongsma, Arthur A M Wilde, Martin B Rook.   

Abstract

BACKGROUND: We previously described a Dutch family in which congenital cardiac conduction disorder has clinically been identified. The ECG of the index patient showed a first-degree AV block associated with extensive ventricular conduction delay. Sequencing of the SCN5A locus coding for the human cardiac Na+ channel revealed a single nucleotide deletion at position 5280, resulting in a frame-shift in the sequence coding for the pore region of domain IV and a premature stop codon at the C-terminus. METHODS AND
RESULTS: Wild type and mutant Na+ channel proteins were expressed in Xenopus laevis oocytes and in mammalian cells. Voltage clamp experiments demonstrated the presence of fast activating and inactivating inward currents in cells expressing the wild type channel alone or in combination with the beta1 subinut (SCN1B). In contrast, cells expressing the mutant channels did not show any activation of inward current with or without the beta1 subunit. Culturing transfected cells at 25 degrees C did not restore the Na+ channel activity of the mutant protein. Transient expression of WT and mutant Na+ channels in the form of GFP fusion proteins in COS-7 cells indicated protein expression in the cytosol. But in contrast to WT channels were not associated with the plasma membrane.
CONCLUSIONS: The SCN5A/5280delG mutation results in the translation into non-function channel proteins that do not reach the plasma membrane. This could explain the cardiac conduction defects in patients carrying the mutation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738236     DOI: 10.1016/s0022-2828(03)00078-6

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

1.  Diseases caused by mutations in Nav1.5 interacting proteins.

Authors:  John W Kyle; Jonathan C Makielski
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

Review 2.  Inherited disorders of voltage-gated sodium channels.

Authors:  Alfred L George
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

3.  Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome.

Authors:  Dan Hu; Hector Barajas-Martinez; Vladislav V Nesterenko; Ryan Pfeiffer; Alejandra Guerchicoff; Jonathan M Cordeiro; Anne B Curtis; Guido D Pollevick; Yuesheng Wu; Elena Burashnikov; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2009-12-16       Impact factor: 1.976

Review 4.  Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.

Authors:  William T Harkcom; Geoffrey W Abbott
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-08

Review 5.  Genetics and Sinus Node Dysfunction.

Authors:  Eyal Nof; Michael Glikson; Charles Antzelevitch
Journal:  J Atr Fibrillation       Date:  2009-04-01

6.  Multiple arrhythmic syndromes in a newborn, owing to a novel mutation in SCN5A.

Authors:  Kirstine Calloe; Nicole Schmitt; Soren Grubb; Ryan Pfeiffer; Jens-Peter David; Ronald Kanter; Jonathan M Cordeiro; Charles Antzelevitch
Journal:  Can J Physiol Pharmacol       Date:  2011-09-06       Impact factor: 2.273

Review 7.  Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 8.  Channelopathies from mutations in the cardiac sodium channel protein complex.

Authors:  Graham S Adsit; Ravi Vaidyanathan; Carla M Galler; John W Kyle; Jonathan C Makielski
Journal:  J Mol Cell Cardiol       Date:  2013-04-01       Impact factor: 5.000

9.  Correlations between clinical and physiological consequences of the novel mutation R878C in a highly conserved pore residue in the cardiac Na+ channel.

Authors:  Y Zhang; T Wang; A Ma; X Zhou; J Gui; H Wan; R Shi; C Huang; A A Grace; C L-H Huang; D Trump; H Zhang; T Zimmer; M Lei
Journal:  Acta Physiol (Oxf)       Date:  2008-07-24       Impact factor: 6.311

10.  A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.

Authors:  Sven Zumhagen; Marieke W Veldkamp; Birgit Stallmeyer; Antonius Baartscheer; Lars Eckardt; Matthias Paul; Carol Ann Remme; Zahurul A Bhuiyan; Connie R Bezzina; Eric Schulze-Bahr
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.